lisocabtagene maraleucel,axicabtagene ciloleucel,ibrutinib,rituximab
gilead,abbvie,janssen,bms,daiichi sankyo
['zuma7', 'triangle', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)']
the jury is still out on whether asct is forgone entirely (though zuma7/transform/triangle/etc suggest that future is nearing). there are global considerations and hard questions we must ask and answer about true equipoise before we declare the death knell of asct. #ash22 3/ 
BMT/Hematology?????????@DanaFarber + @BrighamWomens + @harvardmed | #CareDelivery??| @HPJournalClub | @HarvardChanSPH MPH | @Cornell ‘10 |??Heme & Policy??